Loading the security overview…
Where the tokens are
None held
3 tokenized versions from 3 issuers
See every versionNo venues yet
No vault or pool we index takes these tokens.
Where the tokens are
Key statistics
technicals as of Oct 2, 2026- Market cap
- $244.58B
- P/E
- 110.1EPS $1.43
- 52-week range
- $73.69 – $212.71price at 60% of range
- Volume
- 2.19Maverage day 3.05M
- Previous close
- $157.70
- P/S
- 10.2
- P/B
- 18.1
- Dividend yield
- 1.45%$1.59 a year
- Next ex-dividend
- —
- Next earnings
- Oct 30before the open
- Beta
- -0.3190 days, against SPY
- RSI (14)
- 37.9as of Oct 2
Figures describe AstraZeneca shares, not any token.
Every tokenized version
Search and filter all tokensEach row is one issuer’s token for AstraZeneca, with the chains it is deployed on. A bold chain is one where these wallets hold a balance. Tokens are not shares: no issuer in the registry publishes a shares-per-token ratio, so a balance is counted one per share and marked where that assumption is doing work.
About AstraZeneca PLC
astrazeneca.comA merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
- Type
- Common stock
- Sector
- Healthcare › Pharmaceuticals
- Exchange
- NYSE
- Listed since
- Oct 23, 2009
- Employees
- 96,100
Themes
Healthcare - Oncology › Immunotherapy & Immuno-OncologyBiotech - Drug Development › Metabolic & CardiometabolicHealthcare - Genomics & Precision Medicine › Precision Medicine Platforms
Companies sharing these themesAs the market data provider names it. Where that differs from the issuers’ name for the security, both are shown so the difference is visible.
